|
시장보고서
상품코드
1619111
심혈관 디바이스 시장 규모, 점유율, 성장 분석 : 제품별, 용도별, 최종사용자별, 지역별 - 산업 예측(2024-2031년)Cardiovascular Devices Market Size, Share, Growth Analysis, By Product (Diagnostic & Monitoring Devices, Surgical Devices), By Application (Coronary Artery Disease, Cardiac Arrhythmia), By End User, By Region - Industry Forecast 2024-2031 |
||||||
세계의 심혈관 디바이스 시장 규모는 2022년에 449억 달러로 평가되며, 2023년 491억 달러에서 2031년에는 949억 달러로 성장하며, 예측 기간 중(2024-2031년) CAGR은 8.5%로 성장할 전망입니다.
세계의 심혈관계 기기 시장은 만성 심혈관계 질환의 유병률 증가에 힘입어 강력한 성장세를 보이고 있습니다. 하버드대 T.H. Chan School of Public Health의 연구에 따르면 인도 마하라슈트라 주에서 심장마비가 43% 증가했는데, 이는 관상동맥 스텐트 비용의 감소로 인한 것으로 추정됩니다. 관상동맥 우회술 등 심장 필수 의약품의 가격 하락은 특히 인도와 같은 신흥 경제국에서 시장 확대를 더욱 촉진하고 있습니다. 주요 성장 촉진요인으로는 급속한 기술 발전, 전 세계 심혈관 질환의 부담 증가, 덜 침습적인 치료법으로의 전환 등을 들 수 있습니다. 또한 심장 기기 제조의 기술 혁신으로 적응증 확대와 환자 관리 개선으로 인해 심장 박동기와 같은 기기가 전 세계에서 심장질환의 효과적인 진단과 치료에 중요한 역할을 하고 있음이 밝혀졌습니다.
Global Cardiovascular Devices Market size was valued at USD 44.9 billion in 2022 and is poised to grow from USD 49.1 billion in 2023 to USD 94.9 billion by 2031, growing at a CAGR of 8.5% during the forecast period (2024-2031).
The global cardiovascular device market is experiencing robust growth, driven by the rising incidence of chronic cardiovascular diseases. A study from Harvard's T.H. Chan School of Public Health highlights a 43% surge in cardiac arrests in Maharashtra, India, attributed to the reduced costs of coronary stents. The decline in essential cardiac drug prices, notably coronary artery bypass therapy, is further propelling market expansion, particularly in emerging economies like India. Key growth drivers include rapid technological advancements, a rising global burden of cardiovascular conditions, and a shift towards less invasive treatment options. Additionally, innovation in cardiac device manufacturing has broadened indications and improved patient management, underscoring the vital role of devices like pacemakers in effectively diagnosing and treating heart diseases globally.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cardiovascular Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Cardiovascular Devices Market Segmental Analysis
Global Cardiovascular Devices Market is segmented by product, application, end user and region. Based on product, the market is segmented into Diagnostic & Monitoring Devices (ECG, Implantable Cardiac Monitors, Holter Monitors, Mobile Cardiac Telemetry, MRI, Cardiovascular Ultrasound (2D, 3D/4D, Doppler), Cardiac Diagnostic Catheters, PET Scanner), Surgical Devices (Cardiac Resynchronization Therapy (CRT) (CRT-Defibrillator, CRT-Pacemaker), Implantable Cardioverter Defibrillators (ICDs) (Single Chamber ICDs, Dual Chamber ICDs), Pacemakers (Conventional Pacemakers, Leadless Pacemakers), Coronary Stents, Catheters, Guidewires, Cannula, Valves, Occlusion Devices). Based on application, the market is segmented into Coronary Artery Disease (CAD), Cardiac Arrhythmia, Heart Failure and Others. Based on end user, the market is segmented into Hospitals, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Cardiovascular Devices Market
The Global Cardiovascular Devices market is significantly influenced by the escalating incidence of cardiovascular diseases (CVDs), which remain the foremost cause of mortality worldwide. The rising prevalence of sedentary lifestyles, unhealthy diets, and an aging demographic contributes to an increased risk of conditions like congestive heart failure, hypertension, and heart failure. As a result, there is a growing necessity for vital medical devices, including pacemakers, defibrillators, and stents, particularly in both developed and developing regions. Health systems are now focusing on preventive care and early disease detection, while hospitals and clinics adopt advanced technologies to enhance patient outcomes. Furthermore, government initiatives and nonprofit organizations are actively promoting awareness among high-risk populations, further driving the market's growth.
Restraints in the Global Cardiovascular Devices Market
One significant constraint faced by the global cardiovascular devices market is the high cost associated with advanced equipment. This challenge is particularly pronounced in developing regions where the affordability of advanced devices, such as implantable cardioverter defibrillators (ICDs) and sophisticated imaging technologies, proves to be a substantial hurdle. The hefty price tags attached to these devices can deter healthcare providers and patients alike, limiting their availability and accessibility. Furthermore, inadequate insurance coverage and reimbursement options in certain areas exacerbate this issue, leaving patients without access to potentially life-saving technologies, ultimately hindering the growth and adoption of cardiovascular interventions.
Market Trends of the Global Cardiovascular Devices Market
The Global Cardiovascular Devices market is experiencing a significant shift towards expanding home health solutions, driven by the increasing demand for self-management tools and remote patient monitoring technologies. Wearable ECG devices, blood pressure monitors, and other innovative remote monitoring solutions enable patients to capture real-time health data, empowering them to manage chronic conditions like heart failure more effectively from the comfort of their homes. This trend not only improves patient convenience and engagement but also reduces healthcare costs and enhances the focus on preventive care. As patients seek greater autonomy in managing their health, the market is poised for sustained growth and innovation.